Browse by Condition in Chicago
And 97 more conditions with trials in Chicago
Recruiting Clinical Trials in Chicago
NCT06524544 · Phase 3 · National Cancer Institute (NCI)
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitean-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
NCT03998202 · Wake Forest University Health Sciences
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
NCT06649812 · Phase 2 · National Cancer Institute (NCI)
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
NCT07195734 · Phase 2 · National Cancer Institute (NCI)
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
NCT07293247 · Phase 2 · Alliance for Clinical Trials in Oncology
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
NCT04803201 · Phase 2 · Alliance for Clinical Trials in Oncology
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
NCT06900595 · Phase 2 · National Cancer Institute (NCI)
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
NCT06917911 · Phase 2 · National Cancer Institute (NCI)
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
NCT04640584 · Otto Bock Healthcare Products GmbH
C-Brace Prospective Registry
NCT06756607 · Eastern Cooperative Oncology Group
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
NCT07441681 · Phase 3 · NRG Oncology
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
NCT05646316 · Phase 3 · NRG Oncology
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Top Study Sponsors in Chicago
| Sponsor | Recruiting studies |
|---|---|
| University of Chicago | 141 |
| Northwestern University | 129 |
| University of Illinois at Chicago | 87 |
| Rush University Medical Center | 43 |
| National Cancer Institute (NCI) | 27 |
| Shirley Ryan AbilityLab | 25 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 24 |
| AstraZeneca | 21 |
Trials in Chicago by Phase
| Phase | Studies |
|---|---|
| Early Phase 1 | 20 |
| Phase 1 | 131 |
| Phase 1/2 | 125 |
| Phase 2 | 227 |
| Phase 2/3 | 27 |
| Phase 3 | 147 |
| Phase 4 | 48 |
| Not phased | 716 |
209 of these studies accept healthy volunteers.
Clinical Trials in Chicago: Common Questions
How many clinical trials are recruiting in Chicago, IL?
1441 clinical trials list a recruiting site in Chicago, IL, across 127 conditions on HelloStudys. Counts update daily from ClinicalTrials.gov.
What conditions are being studied in Chicago?
The most active research areas in Chicago right now are ankylosing spondylitis, rheumatoid arthritis, pulmonary embolism. Browse by condition above to see each study.
Who sponsors clinical trials in Chicago?
The sponsors with the most recruiting studies in Chicago include University of Chicago, Northwestern University, University of Illinois at Chicago.
Are there clinical trials for healthy volunteers in Chicago?
Yes. 209 of the recruiting studies in Chicago accept healthy volunteers.
Does it cost anything to join a clinical trial?
Study-related visits, tests and treatment are typically provided at no cost to participants, and some studies reimburse travel or time. Each study sets its own terms, so confirm with the study team before enrolling.
About Clinical Trials in Chicago, IL
Chicago, IL is home to 1441 actively recruiting clinical trials across 127 medical conditions as of 2026. The most active research areas include ankylosing spondylitis, rheumatoid arthritis, pulmonary embolism. Clinical trials offer free access to new treatments and expert medical care. Participation is always voluntary, and you can withdraw at any time.